CSIMarket
 
Optimizerx Corp  (NASDAQ: OPRX)
    Sector  Services    Industry Professional Services
   Industry Professional Services
   Sector  Services
 
Price: $7.8700 $-0.08 -1.006%
Day's High: $7.889999866485596 Week Perf: -1.38 %
Day's Low: $ 7.66 30 Day Perf: 16.77 %
Volume (M): 82,173 52 Wk High: $ 22.25
Volume (M$): $ 0 52 Wk Avg: $10.42
Open: $7.84 52 Wk Low: $4.54



 Market Capitalization (Millions $) 148
 Shares Outstanding (Millions) 19
 Employees 133
 Revenues (TTM) (Millions $) 99
 Net Income (TTM) (Millions $) 5
 Cash Flow (TTM) (Millions $) 4
 Capital Exp. (TTM) (Millions $) 0

Business Description


We are a leading provider of digital health messaging via electronic health records (EHRs), providing a direct channel for pharmaceutical companies to communicate with healthcare providers. Our cloud-based solution supports patient adherence to medications by providing real-time access to financial assistance, prior authorization, education and critical clinical information. Our network is comprised of leading EHR platforms and provides more than half a million healthcare providers access to these benefits within their workflow at the point of care.


   Company Address: 260 Charles Street Waltham 2453 MA
   Company Phone Number: 651-6568   Stock Exchange / Ticker: NASDAQ OPRX


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   



Partnership

OptimizeRx Secures Over $10M Investment in Expanding Strategic Pharma Partnership,

Published Tue, Sep 10 2024 11:30 AM UTC

Waltham, Mass. Sept. 10, 2024 OptimizeRx Corp. (Nasdaq: OPRX), a prominent provider of healthcare technology solutions, has announced an expansion of its strategic relationship with a major pharmaceutical client. The augmentation involves a multi-solution, multi-brand program that brings the client s total commitment for the year to over $10 million. This figure includes a ...

Product Service News

OptimizeRx Unveils Cutting-Edge Marketing Technology Amidst Mixed Financial Results

Published Mon, Sep 9 2024 4:00 PM UTC

In a dynamic move that attests to its innovative prowess, OptimizeRx Corporation has launched a novel brand eligibility technology tailored for the healthcare sector. This advancement significantly enhances the company s Dynamic Audience Activation Platform, effectively enabling more personalized and timely direct-to-consumer marketing endeavors. This strategic development c...

Product Service News

OptimizeRx Unveils AI-Driven Privacy-Compliant Marketing Platform Amid Mixed Financial Results

Published Tue, Jul 23 2024 11:30 AM UTC

OptimizeRx Unveils Cutting-Edge AI-Driven Platform Amid Increasing Privacy Regulations OptimizeRx, a leading provider of digital health solutions for the pharmaceutical industry, has introduced a groundbreaking AI-guided platform designed to provide privacy-compliant marketing solutions. This innovation arrives at a crucial time as consumer privacy regulations continue to ev...

Product Service News

Optimizerx Corporations AI-guided Platform Delivers Promising Results, Boosting Efficiency for Depressive Disorder B...

Published Mon, Jul 15 2024 11:30 AM UTC

In the realm of healthcare, where effective communication is crucial, Optimizerx Corporation has successfully revolutionized its marketing strategy for a major depressive disorder brand. Leveraging their innovative AI-guided predictive targeting platform, the company has achieved remarkable success, delivering three times the return in half the time compared to traditional t...

Product Service News

OptimizeRx: Empowering Healthcare Providers and Steadily Growing Amidst Competition

Published Mon, Mar 4 2024 8:51 PM UTC

OptimizeRx: Empowering Healthcare Providers and Steadily Growing Amidst Tough CompetitionIn today s ever-evolving healthcare landscape, optimizing patient care and removing barriers to access have become paramount goals for healthcare providers. OptimizeRx, a leading provider of digital health messaging solutions, has been at the forefront of this mission, particularly throu...




Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) 34.22
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) 1.50
Price to Sales (Expected) -
Price to Book 1.13
PEG (TTM) -

Financial Strength Current
Quick Ratio 2.48
Working Capital Ratio 5.98
Leverage Ratio (MRQ) 0.25
Total Debt to Equity 0.16
Interest Coverage (TTM) -
Debt Coverage (TTM) 0.58

Per Share Current
Earnings (TTM) 0.23 $
Revenues (TTM) 5.25 $
Cash Flow (TTM) 0.19 $
Cash 1.28 $
Book Value 6.98 $
Dividend (TTM) 0 $

Efficiency Current
Revenue per Employee (TTM) 741,759
Net Income per Employee (TTM) 34,594
Receivable Turnover Ratio (TTM) 3.11
Inventory Turnover Ratio (TTM) -
Asset Turnover Ratio (TTM) 0.58

Profitability Ratios Current
Gross Margin (MRQ) 76.51 %
Operating Margin (MRQ) -0.43 %
Net Margin (MRQ) -3.43 %
Net Cash Flow Margin (MRQ) 0 %
Effective Tax Rate (TTM) 32.15 %

Management Effectiveness Current
Return On Assets (TTM) 2.7 %
Return On Investment (TTM) 2.97 %
Return On Equity (TTM) 3.6 %
Dividend Yield -
Pay out Ratio (TTM) -



Optimizerx's Segments
Solutions Sold on a Commissions Bases, Agent Revenue Recognized on a Net Basis    39.45 % of total Revenue

  Optimizerx Outlook

On April 26 2024 the Optimizerx provided following guidance

Optimizerx Corporation expects strong revenue growth in the first quarter of 2024, with an estimated increase of over 40% compared to the previous year. The company anticipates revenue to fall within the range of $18.5 million to $19.2 million.

This revenue growth can be attributed to the continued success of Optimizerx's innovative solutions and services, which have been well-received by healthcare providers and pharmaceutical companies. The company's ability to adapt to market demands and deliver value to its customers has led to this impressive financial performance.

Investors and stakeholders can learn more about Optimizerx's first-quarter results during the upcoming conference call schedul...





Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.